Second-line drug susceptibilities of multidrug- and rifampicin-resistant Mycobacterium tuberculosis isolates in Delhi

Second-line drug susceptibilities of multidrug- and rifampicin-resistant Mycobacterium tuberculosis isolates in Delhi

Background: Multidrug-resistant tuberculosis (MDR-TB) is a threat to the accomplishments of the World Health Organization's (WHO) End TB Strategy. The treatment of MDR-TB is less effective and more toxic; additional resistance to second-line drugs makes the treatment more difficult. India accou...

Full description

Bibliographic Details
Main Authors: Zeeshan Sidiq, M Hanif, K K Chopra, Ashwani Khanna, Indrani Jadhav, Kaushal Kumar Dwivedi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Biomedical and Biotechnology Research Journal
Subjects:
Drug-susceptibility testing
extensively drug resistant
multidrug resistant
Mycobacterium tuberculosis
rifampicin-resistant tuberculosis
Online Access:http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2019;volume=3;issue=2;spage=87;epage=91;aulast=Sidiq

Internet

http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2019;volume=3;issue=2;spage=87;epage=91;aulast=Sidiq

Similar Items